HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the second quarter of fiscal 2024.
HealthEquity, Inc. (NASDAQ:HQY ) Q2 2024 Earnings Conference Call September 5, 2023 4:30 PM ET Company Participants Richard Putnam - Investor Relations Jon Kessler - President & Chief Executive Office
HealthEquity (HQY) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.33 per share a year ago.
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2023, it could be worth looking at how some of its key metrics compar
Here is how HealthEquity (HQY) and InMode (INMD) have performed compared to their sector so far this year.
HealthEquity is the largest player in the Health Savings Account market, with a 20% market share and the most assets under management. The company offers other consumer-directed benefits, such as flex
The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and SGRY are set to gain the most.
HealthEquity's (HQY) strength in HSA raises optimism about the stock.
Investors interested in Medical Services stocks are likely familiar with Thorne Healthtech, Inc. (THRN) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for t
DRAPER, Utah, Aug. 08, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today annou
HealthEquity's (HQY) strength in HSA raises optimism about the stock.

New Strong Buy Stocks for July 20th

09:09am, Thursday, 20'th Jul 2023
HQY, SKFRY, AZEK, CIR and ATR have been added to the Zacks Rank #1 (Strong Buy) List on July 20, 2023.
Here is how HealthEquity (HQY) and McKesson (MCK) have performed compared to their sector so far this year.

2 Medical Stocks to Consider Buying in June

09:52pm, Wednesday, 28'th Jun 2023
With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.
Investors continue to be optimistic about HealthEquity's (HQY) strength in HSA.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE